1. Allogeneic Haematopoietic Stem Cell Transplantation as Therapy for Chronic Granulomatous Disease-Single Centre Experience.
- Author
-
Goździk, Jolanta, Pituch-Noworolska, Anna, Skoczeń, Szymon, Czogała, Wojciech, Baran, Jarosław, Krasowska-Kwiecień, Aleksandra, Wiecha, Oktawiusz, and Zembala, Marek
- Subjects
CHRONIC granulomatous disease ,GRANULOMA ,GRAFT rejection ,CYCLOPHOSPHAMIDE ,FLUDARABINE ,SUPEROXIDES ,METHOTREXATE - Abstract
Chronic granulomatous disease (CGD) is phagocytic cell metabolic disorder resulting in recurrent infections and granuloma formation. This paper reports the favourable outcome of allogeneic transplantation in six high-risk CGD patients. The following donors were used: HLA-matched, related (two) and unrelated (three), and HLA-mismatched, unrelated (one). One patient was transplanted twice using the same sibling donor because of graft rejection at 6 months after reduced-intensity conditioning transplant (fludarabine and melphalan). Myeloablative conditioning regimen consisted of busulphan and cyclophosphamide. Stem cell source was unmanipulated bone marrow containing: 5.2 (2.6-6.5) × 10 nucleated cells, 3.8 (2.0-8.0) × 10 CD34+ cells and 45 (27-64) × 10 CD3+ cells per kilogramme. Graft-versus-host disease prophylaxis consisted of cyclosporine A and, for unrelated donors, short course of methotrexate and anti-T-lymphocyte globulin. Mean neutrophile and platelet engraftments were observed at day 22 (20-23) and day 20 (16-29), respectively. Pre-existing infections and inflammatory granulomas resolved. With the follow-up of 4-35 months (mean, 20 months), all patients are alive and well with full donor chimerism and normalized superoxide production. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF